Mariana Soares da Cal

Mariana Soares da Cal

Auto-generated profile, based on publicly available information

Mariana Soares da Cal

Department of Pneumology, University Hospital Pedro Ernesto, State University of Rio de Janeiro (UERJ), Rio de Janeiro, RJ, Brazil

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 April 2023 in PLOS ONE
Verified
Journal Article
Open access
PDF file
SGShayane Martins Rodrigues Gomes
Shayane Martins Rodrigues Gomes
ABAndréia Carolinne de Souza Brito
Andréia Carolinne de Souza Brito
WMWânia Ferraz Pereira Manfro
Wânia Ferraz Pereira Manfro
MRMarcelo Ribeiro-Alves
Marcelo Ribeiro-Alves
RRRoberto Stefan de Almeida Ribeiro
Roberto Stefan de Almeida Ribeiro
LRLuciana Rodrigues
Luciana Rodrigues
Background: Cytokines induced by SARS-CoV-2 infection play a crucial role in the pathophysiology of COVID-19 and hyperinflammatory responses have been associated with poor clinical outcomes, with progression to severe conditions or long-term subacute complications named as long-COVID-19. Methods: In this cross-sectional study, we aimed to evaluate a set of antigen-specific inflammatory cytokines in blood from recovered COVID-19 individuals or who suffered a post-acute phase of SARS-CoV-2 infection compared to healthy individuals with no history of COVID-19 exposition or infection. Interferon-gamma (IFN-γ), IFN-γ-induced protein 10 (IP-10), tumor necrosis factor (TNF), IL-1β, IL-2, IL-4, IL-6, IL-8, IL-10, IL-12, and IL-17A were quantified by multiplex cytometric bead assay and enzyme-linked immunosorbent assay after stimulation of whole blood with recombinant Spike protein from SARS-CoV-2. Additionally, all participants have evaluated for anti-(S) protein-specific IgG antibodies. Clinical specimens were collected within two months of COVID-19 diagnosis. Results: A total of 47 individuals were enrolled in the study, a median age of 43 years (IQR = 14.5), grouped into healthy individuals with no history of infection or exposure to SARS-CoV-2 (unexposed group; N = 21); and patients from the Health Complex of the Rio de Janeiro State University (UERJ), Brazil, who were SARS-CoV-2 positive by RT-PCR (COVID-19 group)–categorized as recovered COVID-19 (N = 11) or long-COVID-19 (N = 15). All COVID-19 patients presented at least one signal or symptom during the first two weeks of infection. Six patients were hospitalized and required invasive mechanical ventilation. Our results showed that COVID-19 patients had significantly higher levels of IFN-γ, TNF, IL-1β, IL-2, IL-6, IL-8, and IP-10 than the unexposed group. The long-COVID-19 group has presented significantly high levels of IL-1β and IL-6 compared to unexposed individuals, but not from recovered COVID-19. A principal-component analysis demonstrated 84.3% of the total variance of inflammatory-SARS-CoV-2 response in the first two components, and it was possible to stratify IL-6, TNF, IL-1β, IL-10, and IL-2 as the top-five cytokines which are candidates to discriminate COVID-19 group (including long-COVID-19 subgroup) and healthy unexposed individuals. Conclusion: We revealed important S protein-specific differential biomarkers in individuals affected by COVID-19, bringing new insights into the inflammatory status or SARS-CoV-2 exposition determination.

29 November 2021 in PLOS ONE
Verified
Journal Article
Open access
PDF file
Agnaldo José LopesAgnaldo José Lopes
Agnaldo José Lopes
PLPatrícia Frascari Litrento
Patrícia Frascari Litrento
BPBruna CUOCO PROVENZANO
Bruna CUOCO PROVENZANO
ACAlícia Sales Carneiro
Alícia Sales Carneiro
LMLaura Braga Monnerat
Laura Braga Monnerat
TMThiago Thomaz Mafort
Thiago Thomaz Mafort
Background: Thousands of people worldwide are suffering the consequences of coronavirus disease-2019 (COVID-19), and impulse oscillometry (IOS) and lung ultrasound (LUS) might be important tools for the follow-up of this population. Our objective was to prospectively evaluate abnormalities detected using these two methods in a cohort of COVID-19 survivors with respiratory symptoms. Methods: In this follow-up study, 59 patients underwent clinical evaluations, spirometry, IOS and LUS in the 2nd (M1) and 5th (M2) months after diagnostic confirmation of COVID-19 by real-time reverse transcriptase–polymerase chain reaction. Aeration scores were obtained from the LUS exams based on the following findings: B-lines >2, coalescent B-lines, and subpleural consolidations. Results: Fifty-nine (100%) participants had cough and/or dyspnea at M1, which decreased to 38 (64.4%) at M2 (p = 0.0001). Spirometry was abnormal in 26 (44.1%) and 20 (33.9%) participants at M1 and M2, respectively, although without statistical significance (p = 0.10). Normal examination, restrictive patterns, and obstructive patterns were observed in 33 (55.9%), 18 (30.5%), and 8 (13.6%) participants, respectively, at M1 and in 39 (66.1%), 13 (22%), and 7 (11.9%) participants at M2 (p = 0.14). Regarding IOS, considering changes in resistive and reactive parameters, abnormal exams were detected in 52 (88.1%) and 42 (71.2%) participants at M1 and M2, respectively (p = 0.002). Heterogeneity of resistance between 4 and 20 Hz >20% was observed in 38 (64.4%) and 33 (55.9%) participants at M1 and M2, respectively (p = 0.30). Abnormal LUS was observed in 46 (78%) and 36 (61%) participants at M1 and M2, respectively (p = 0.002), with a reduction in aeration scores between M1 and M2 [5 (2–8) vs. 3 (0–6) points, p<0.0001]. Conclusions: IOS and LUS abnormalities are frequent in the first 5 months post-COVID-19 infection; however, when prospectively evaluated, significant improvement is evident in the parameters measured by these two methods.

9 April 2021 in The Ultrasound Journal
Verified
Journal Article
Open access
PDF file
MMMafort Mafort
Mafort Mafort
RRRogerio Rufino
Rogerio Rufino
CCClaudia HENRIQUE Costa
Claudia HENRIQUE Costa
MCMariana Soares da Cal
Mariana Soares da Cal
LMLaura Braga Monnerat
Laura Braga Monnerat
Agnaldo José LopesAgnaldo José Lopes
Agnaldo José Lopes
Background: The role of lung ultrasound (LUS) in evaluating the mid- and long-term prognoses of patients with COVID-19 pneumonia is not yet known. The objectives of this study were to evaluate associations between LUS signs at the time of screening and clinical outcomes 1 month after LUS and to assess LUS signs at the time of presentation with known risk factors for COVID-19 pneumonia. Methods: This was a retrospective study of data prospectively collected 1 month after LUS screening of 447 adult patients diagnosed with COVID-19 pneumonia. Sonographic examination was performed in screening tents with the participants seated. The LUS signs (B-lines > 2, coalescent B-lines, and subpleural consolidations) were captured in six areas of each hemithorax and a LUS aeration score was calculated; in addition, the categories of disease probability based on patterns of LUS findings (high-probability, intermediate-probability, alternate, and low-probability patterns) were evaluated. The LUS signs at patients’ initial evaluation were related to the following outcomes: symptomatology, the need for hospitalization or invasive mechanical ventilation (IMV), and COVID-19-related death. Results: According to the evaluations performed 1 month after LUS screening, 36 patients were hospitalised, eight of whom required intensive care unit (ICU) admission and three of whom died. The presence of coalescent B-lines was associated with the need for hospitalization ( p = 0.008). The presence of subpleural consolidations was associated with dyspnoea ( p < 0.0001), cough ( p = 0.003), the need for hospitalization ( p < 0.0001), the need for ICU admission ( p < 0.0001), and death ( p = 0.002). A higher aeration score was associated with dyspnoea ( p < 0.0001), the need for hospitalization ( p < 0.0001), the need for ICU admission ( p < 0.0001), and death ( p = 0.003). In addition, patients with a high-probability LUS pattern had a higher aeration score ( p < 0.0001) and more dyspnoea ( p = 0.024) and more often required hospitalization ( p < 0.0001) and ICU admission ( p = 0.031). Conclusions: In patients with COVID-19 pneumonia, LUS signs were related to respiratory symptoms 1 month after LUS screening. Strong relationships were identified between LUS signs and the need for hospitalization and death.

5 May 2022 in Radiology Research and Practice
Verified
Journal Article
Open access
PDF file
RMRoberto Mogami
Roberto Mogami
RFRonaldo Carvalho Araújo Filho
Ronaldo Carvalho Araújo Filho
CCCarolina Gianella Cobo Chantong
Carolina Gianella Cobo Chantong
FAFernando Carlos Santos de Almeida
Fernando Carlos Santos de Almeida
AKAna Célia Baptista Koifman
Ana Célia Baptista Koifman
Agnaldo José LopesAgnaldo José Lopes
Agnaldo José Lopes
Postacute COVID-19 has become a relevant public health problem, and radiological and pulmonary function tests are tools that help physicians in decision-making. The objectives of this study are to characterize the findings and patterns on a chest radiograph (CXR) and computed tomography (CT) that are most important in the postacute phase and to evaluate how these changes correlate with clinical data, spirometry, and impulse oscillometry (IOS). This was a retrospective study of 29 patients who underwent CXR, CT, spirometry, and IOS. The inclusion criteria were age >18 years and persistent respiratory symptoms after four weeks. The exclusion criteria were radiological exams with low technical quality and non-COVID-19 acute lung diseases. The inferential analysis was carried out with the chi-square (χ2) or Fisher’s exact test to evaluate the interrelationships between the clinical and COVID-19 variables according to spirometry, IOS, CT, and CXR. In our sample, 19 patients were women (65.5%). The predominance of abnormal spirometry was associated with CT’s moderate/severe degree of involvement ( = 0.017; 69.2%, CI 95%: 44.1%–94.3%). There was no significant association between IOS and tomographic and radiographic parameters. A significant association was found between the classifications of the moderate/severe and normal/mild patterns on CT and CXRs ( = 0.003; 93.3%, CI 95%: 77.8%–100%). Patients with moderate/severe impairment on CXR were associated with a higher frequency of hospitalization ( = 0.033; 77.8%, CI 95%: 58.6%–97.0%) and had significantly more moderate/severe classifications in the acute phase than the subgroup with normal/mild impairment on CXR ( = 0.017; 88.9%, CI 95%: 74.4%–100%). In conclusion, the results of this study show that CXR is a relevant examination and may be used to detect nonspecific alterations during the follow-up of post-COVID-19 patients. Small airway disease is an important finding in postacute COVID-19 syndrome, and we postulate a connection between this pattern and the persistently low-level inflammatory state of the lung.

16 May 2023 in American Journal of Case Reports
Verified
Journal Article
Open access
LMLaura Braga Monnerat
Laura Braga Monnerat
ELElisa Barbosa Louzada
Elisa Barbosa Louzada
VBVanessa Godinho Souza Braga
Vanessa Godinho Souza Braga
MCMariana Soares da Cal
Mariana Soares da Cal
Agnaldo José LopesAgnaldo José Lopes
Agnaldo José Lopes
MMMafort Mafort
Mafort Mafort
Objective: Rare disease Background: Pseudochylothorax is a rare entity, with only a few hundred case reports worldwide. It presents as a pleural effusion rich in lipids, typically with a cloudy, milky appearance. The diagnosis is made based on the levels of cholesterol and triglycerides in the pleural fluid.Case Report: This is the case report of a 55-year-old woman with a history of pleuropulmonary tuberculosis that was treated in childhood, with a new infection and treatment in adulthood that evolved to a left pleural effusion. Thirteen years after completing her last treatment for tuberculosis, the patient developed general fatigue and dyspnea on exertion. Computed tomography of the chest confirmed the presence of a pleural collection in the same lo-cation as in adolescence, suggesting a chronic evolution with encystation. The patient underwent ultrasound -guided diagnostic thoracentesis. The collected liquid was thick, chocolate-colored, with the following biochemical characteristics: pH, 7.3; glucose, 37.9 mg/dL; LDL, 2059.8 IU/L; total protein, 8.8 mg/dL; triglycerides, 90 mg/dL; adenosine deaminase, 56 U/L; and cholesterol, 300 mg/dL. The effusion was characterized as a pseudochylo-thorax. The cell count showed 631 000 leukocytes/& mu;L, with 87.9% polymorphonuclear cells. Owing to the pa-tient's respiratory symptoms, an evacuatory thoracentesis was performed. After the procedure, the patient's symptoms improved.Conclusions: Although pseudochylothorax is a rare condition, its possibility must always be kept in mind to avoid the haz-ards of misdiagnosis. In addition to the 'classic' milky and machine oil appearance, a chocolate-colored appear-ance should also serve as a clue to the diagnosis of pseudochylothorax.